SCHEMBL3155589

SCHEMBL3155589

CC(=O)NCCNc1cc(N2CCN(C(=O)Cc3cccc([N+](=O)[O-])c3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.47
HRH4 Q9H3N8 1/20 0.46
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 5/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
GBA1 P04062 1/20 0.42
MAPT P10636 2/20 0.42
MET P08581 1/20 0.41
PDE5A O76074 1/20 0.40
ADORA2B P29275 2/20 0.40
TP53 P04637 1/20 0.40
ABCC1 P33527 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
KDM6B O15054 2/20 0.40
LMNA P02545 2/20 0.40
NR1I2 O75469 1/20 0.40
CHRNA1 P02708 1/20 0.40
MAOB P27338 1/20 0.40
OPRM1 P35372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162285 0.93 HRH4 (0.44) SIGMAR1HRH4MEN1KMT2AALDH1A1
SCHEMBL3177354 0.92 KMT2A (0.49) SIGMAR1MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL3170848 0.89 GBA1 (0.52) HRH4KMT2AALDH1A1GBA1ADORA2B
SCHEMBL3155851 0.88 MAPT (0.53) HRH4MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL3174442 0.88 GBA1 (0.47) HRH4ALDH1A1GBA1MAPTADORA2B
SCHEMBL3176827 0.87 TSHR (0.49) SIGMAR1MEN1KMT2AALDH1A1L3MBTL1
SCHEMBL3172646 0.86 GBA1 (0.48) HRH4KMT2AALDH1A1L3MBTL1GBA1
SCHEMBL3166317 0.85 ITGB2 (0.53) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL3166308 0.85 ITGB2 (0.53) MEN1KMT2AALDH1A1L3MBTL1MAPT
SCHEMBL3176585 0.85 GBA1 (0.43) ALDH1A1GBA1MAPTADORA2BKDM6B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed